Valeur202020212022202320242025TTMFrais de vente, généraux et administratifs384.13 M459.57 M566.29 M628.02 M662.47 M729.54 M729.54 MRecherche et développement294.22 M382.04 M520.28 M629.03 M693.08 M767.39 M767.39 MRésultat d'exploitation377.79 M505.5 M459.09 M429.33 M691.43 M916.37 M916.37 MTotal des produits hors exploitation15.76 M-318 K52.61 M183.85 M247.29 M270.13 M260.14 MCharges d'intérêts, nettes des intérêts capitalisés———————Résultat hors exploitation, hors charges d'intérêts-442 K-7.13 M2.6 M25.16 M19.35 M-8.01 M-18 MRevenus/dépenses exceptionnels16.2 M6.82 M50.01 M158.69 M227.95 M278.14 M278.14 MRésultat avant impôts393.99 M512.31 M509.1 M588.02 M919.38 M1.19 B1.19 BPart des actionnaires dans le résultat———————Impôts13.99 M84.92 M21.39 M62.32 M205.24 M285.6 M285.6 MIntérêts ne donnant pas le contrôle / intérêts minoritaires———————Autres produits/charges après impôts———————Résultat net avant activités abandonnées380 M427.39 M487.71 M525.71 M714.14 M908.91 M908.91 MActivités abandonnées———————Résultat net380 M427.39 M487.71 M525.71 M714.14 M908.91 M908.91 MAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires439.54 M490.08 M553.15 M568.55 M714.14 M908.91 M908.91 MBénéfice par action de base (BPA de base)2.522.793.143.273.273.275.55Bénéfice par action dilué (BPA dilué)2.362.6333.223.223.225.44Nombre moyen d'actions de base en circulation135.55 M138.47 M140.64 M150.16 M150.16 M150.16 M—Nombre d'actions en circulation après dilution160.73 M162.28 M162.44 M163.49 M163.49 M163.49 M—EBITDA439.38 M565.21 M509.59 M460.45 M725.38 M958.65 M970.65 MEBIT377.79 M505.5 M459.09 M429.33 M691.43 M916.37 M916.37 MCoût des ventes408.93 M503.68 M609.4 M677.29 M699.64 M782.02 M782.02 MAutres coûts des ventes———————Amortissements (flux de trésorerie)61.59 M59.71 M50.5 M31.11 M33.94 M42.28 M54.28 M
Veeva Systems Inc. Class A Common Stock
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry. Its products are used to track all aspects of drug development and pharmaceutical manufacturing.
The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia. Its primary competitor for its customer relationship management software is Salesforce, which is partnered with IQVIA.